Neo7Bioscience
Neo7Bioscience is dedicated to advancing personalized medicine through innovative, AI-driven molecular designs and therapeutics. With a focus on personalized peptide therapies, the company aims to treat active diseases, prevent disease, and enhance longevity by utilizing a multi-omics approach and proprietary technology platform. Their mission is to change the face of medicine for current and future generations by providing ground-breaking therapeutics based on individual genetic and molecular data.
Industries
Nr. of Employees
small (1-50)
Patents
Precision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine
US-12525329-B2
View DetailsPrecision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine
US-11887710-B2
View Details
Precision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine
US-12525329-B2
View DetailsPrecision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine
US-11887710-B2
View DetailsProducts
Individualized peptide therapy for active disease
A personalized peptide therapeutic program guided by multi-omics and immune-specific surveillance to identify and treat faulty signaling pathways in active diseases (e.g., cancer, autoimmune, neurodegenerative, viral conditions).
Multi-pathway resilience panel
A molecular panel targeting multiple homeostatic and longevity-related pathways (eg. telomere, inflammation/immune, mitochondrial, DNA repair, autophagy, metabolic and hormonal balance) for system-wide functional optimization.
Viral and mRNA-associated molecular panel
A molecular assessment and panel focused on disruptions associated with viral infections and mRNA-related effects, addressing RNA transcription, protein integrity, and immune recalibration to inform personalized treatment strategies.
Individualized peptide therapy for active disease
A personalized peptide therapeutic program guided by multi-omics and immune-specific surveillance to identify and treat faulty signaling pathways in active diseases (e.g., cancer, autoimmune, neurodegenerative, viral conditions).
Multi-pathway resilience panel
A molecular panel targeting multiple homeostatic and longevity-related pathways (eg. telomere, inflammation/immune, mitochondrial, DNA repair, autophagy, metabolic and hormonal balance) for system-wide functional optimization.
Viral and mRNA-associated molecular panel
A molecular assessment and panel focused on disruptions associated with viral infections and mRNA-related effects, addressing RNA transcription, protein integrity, and immune recalibration to inform personalized treatment strategies.
Services
Generation and analysis of WES, RNA transcriptome, proteomics, exosomal proteomics, HLA phenotyping, and cfDNA/ctDNA to create a comprehensive molecular profile.
Design of individualized peptide sequences based on integrated molecular and immune data to address patient-specific faulty signaling pathways.
Coordination with cGMP-certified, US-based manufacturing for production of lyophilized, custom peptides and guidance on storage and handling.
Bioinformatics-driven interpretation of molecular data, generation of clinical reports to guide therapy, and post-analysis support including educational resources.
Design and support for standardized sample collection kits and handling workflows to preserve sample integrity prior to analysis.
Generation and analysis of WES, RNA transcriptome, proteomics, exosomal proteomics, HLA phenotyping, and cfDNA/ctDNA to create a comprehensive molecular profile.
Design of individualized peptide sequences based on integrated molecular and immune data to address patient-specific faulty signaling pathways.
Coordination with cGMP-certified, US-based manufacturing for production of lyophilized, custom peptides and guidance on storage and handling.
Bioinformatics-driven interpretation of molecular data, generation of clinical reports to guide therapy, and post-analysis support including educational resources.
Design and support for standardized sample collection kits and handling workflows to preserve sample integrity prior to analysis.
Expertise Areas
- Personalized peptide therapeutics
- Multi-omics analysis and integration
- AI-driven bioinformatics and target identification
- Proteomics including exosomal proteomics
Key Technologies
- Whole exome sequencing (WES)
- RNA transcriptomics
- Mass spectrometry proteomics
- Exosomal proteomics
News & Updates
A4M (Fall)
A4M (Fall) conference focusing on functional and integrative medicine, December 14-16, 2023.
AAMP (Fall)
AAMP Fall conference on oncology-focused CME, October 13-15, 2023.
RAAD Festival
Longevity solutions and future of health, September 7-9, 2023.
Immuno-Oncology Summit
Leading conference on biotherapeutics and cellular therapies, August 7-9, 2023.
ISSRDC
International Space Station Research Development Conference, July 31 - August 3, 2023.
AAMP (Spring)
Spring oncology-focused CME, May 19-21, 2023.
A4M (Fall)
A4M (Fall) conference focusing on functional and integrative medicine, December 14-16, 2023.
AAMP (Fall)
AAMP Fall conference on oncology-focused CME, October 13-15, 2023.
RAAD Festival
Longevity solutions and future of health, September 7-9, 2023.
Immuno-Oncology Summit
Leading conference on biotherapeutics and cellular therapies, August 7-9, 2023.
ISSRDC
International Space Station Research Development Conference, July 31 - August 3, 2023.
AAMP (Spring)
Spring oncology-focused CME, May 19-21, 2023.